Abstract
Get full access to this article
View all access options for this article.
References
1.
Pazanowski
MA.
Henrietta Lacks' Family Settles Lawsuit Over Use of Famed Cells. August 10, 2023. Available from: https://news.bloomberglaw.com/litigation/thermo-fisher-lacks-estate-settle-suit-over-cell-line-use [Last accessed: August 12, 2023].
2.
Lacks
RL.
Personal Representative of the Estate of Henrietta L. Lacks, v. Ultragenyx Pharmaceutical. Filed August 10, 2023, in U.S. District Court for the District of Maryland, Baltimore Division. Case No. 21-cv-2524-DLB. Published by Bloomberg Law. Available from: https://www.bloomberglaw.com/public/desktop/document/LacksvULTRAGENYXPHARMACEUTICALINCDocketNo123cv02171DMdAug102023Co?doc_id=X7CB11EQLP59Q3R42SCH4B0P3VV [Last accessed: August 12, 2023].
3.
Goodwin
K.
AstraZeneca, Pfizer Ink Potential $1B Gene Therapy Deal. BioSpace, July 28, 2023. Available from: https://www.biospace.com/article/astrazeneca-pfizer-ink-potential-1b-gene-therapy-deal-/ [Last accessed: August 11, 2023].
4.AstraZeneca . Alexion, AstraZeneca Rare Disease, Enters Agreement with Pfizer to Acquire a Portfolio of Preclinical Rare Disease Gene Therapies. July 28, 2023. Available from: https://www.astrazeneca.com/media-centre/press-releases/2023/alexion-enters-gene-therapy-agreement-with-pfizer.html [Last accessed: August 11, 2023].
5.Regeneron Pharmaceuticals and Decibel Therapeutics . Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs. August 9, 2023. Available from: https://investor.regeneron.com/news-releases/news-release-details/regeneron-acquire-decibel-therapeutics-strengthening-gene [Last accessed: August 11, 2023].
6.Taysha Gene Therapies . Taysha Gene Therapies Announces $150 Million Private Placement Financing. August 14, 2023. Available from: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-150-million-private-placement [Last accessed: August 14, 2023].
7.Neurophth Therapeutics . Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials. August 11, 2023. Available from: https://www.prnewswire.com/news-releases/neurophth-secures-nearly-95-million-usd-in-series-c-financing-for-gene-therapy-clinical-trials-301898549.html [Last accessed: August 11, 2023].
8.Correction: 10X Capital Venture Acquisition Corp . III. Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III. August 9. Available from: https://www.globenewswire.com/news-release/2023/08/10/2722273/0/en/Correction-Addimmune-a-Clinical-Stage-HIV-Focused-Gene-Therapy-Company-to-go-Public-Through-Business-Combination-With-10X-Capital-Venture-Acquisition-Corp-III.html [Last accessed: August 11, 2023].
9.Astellas Pharma and Poseida Therapeutics . Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy. August 8, 2023. Available from: https://www.astellas.com/en/news/28271 [Last accessed: August 12, 2023].